Skip to content
Register for Symposium
Menu
About HFA
Our Story
Our Team
Our Board
Our Sponsors
Our Work
Assisting
Educating
Advocating
Learn
History of Bleeding Disorders
Bleeding Disorders 101
Learning Central
Financial Assistance
Helping Hands
Emergency Assistance
Items Assistance
Inhibitor Support
Disaster Relief
Job Readiness Grants
Scholarships
Get Connected
Join Blood Sisterhood
Join Blood Brotherhood
Join Sangre Latina
Contact Your Legislator
Apply for an Internship
Become a Member
Locate
Member Organizations
Hemophilia Treatment Centers
Summer Camps
Resources
Events
All Events
Symposium 2023
News
Donate
Search
CSL Behring Receives FDA Approval of Corifact™ for Treatment of Congenital Factor XIII Deficiency
February 23, 2011
Share on facebook
Share on twitter
Share on linkedin
View Press Release
Read more news.
Industry News
BioMarin Update: FDA Extends PDUFA Target Action Date to June 30, 2023
March 7, 2023
Word From Washington
The Complexity of Unwinding Medicaid
February 28, 2023
Industry News
FDA Approves Sanofi’s Once-Weekly ALTUVIIIO™
February 23, 2023
